Your browser doesn't support javascript.
loading
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial.
Leroux-Roels, Isabel; Davis, Matthew G; Steenackers, Katie; Essink, Brandon; Vandermeulen, Corinne; Fogarty, Charles; Andrews, Charles P; Kerwin, Edward; David, Marie-Pierre; Fissette, Laurence; Vanden Abeele, Carline; Collete, Delphine; de Heusch, Magali; Salaun, Bruno; De Schrevel, Nathalie; Koch, Juliane; Verheust, Céline; Dezutter, Nancy; Struyf, Frank; Mesaros, Narcisa; Tica, Jelena; Hulstrøm, Veronica.
  • Leroux-Roels I; Center for Vaccinology, Ghent University Hospital, Ghent, Belgium.
  • Davis MG; Rochester Clinical Research, Rochester, New York, USA.
  • Steenackers K; Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
  • Essink B; Meridian Clinical Research Omaha, Omaha, Nebraska, USA.
  • Vandermeulen C; Department of Public Health and Primary Care, Leuven University Vaccinology Center, KU Leuven, Leuven, Belgium.
  • Fogarty C; Lung and Chest Medical Associates, Spartanburg Medical Research, Spartanburg, South Carolina, USA.
  • Andrews CP; IMA Clinical Research, San Antonio, Texas, USA.
  • Kerwin E; Crisor, LLC, c/o Clinical Research Institute of Southern Oregon, Medford, Oregon, USA.
  • David MP; GSK, Wavre, Belgium.
  • Fissette L; GSK, Wavre, Belgium.
  • Vanden Abeele C; GSK, Wavre, Belgium.
  • Collete D; GSK, Rixensart, Belgium.
  • de Heusch M; GSK, Wavre, Belgium.
  • Salaun B; GSK, Rixensart, Belgium.
  • De Schrevel N; GSK, Rixensart, Belgium.
  • Koch J; GSK, Wavre, Belgium.
  • Verheust C; GSK, Wavre, Belgium.
  • Dezutter N; GSK, Wavre, Belgium.
  • Struyf F; GSK, Wavre, Belgium.
  • Mesaros N; GSK, Wavre, Belgium.
  • Tica J; GSK, Wavre, Belgium.
  • Hulstrøm V; GSK, Wavre, Belgium.
J Infect Dis ; 227(6): 761-772, 2023 03 28.
Article en En | MEDLINE | ID: mdl-35904987

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Vacunas contra Virus Sincitial Respiratorio Tipo de estudio: Clinical_trials Límite: Adult / Aged / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Vacunas contra Virus Sincitial Respiratorio Tipo de estudio: Clinical_trials Límite: Adult / Aged / Humans Idioma: En Año: 2023 Tipo del documento: Article